Specialized diagnostic tool designed to screen for diabetic retinopathy in patients with diabetes mellitus. Utilizes artificial intelligence to detect retinal alterations indicative of disease progression. Provides rapid assessment without the need for dilating drops or specialized ophthalmologic eq...
Manufactured by
CHECK-EYE
München, Germany
CHECK-EYE develops AI-powered retinal screening technology for early detection of diabetic retinopathy and other eye conditions. The company provides cloud-based diagnostic solutions that analyze retinal images to identify changes before symptoms appear. Products are deployed through pharmacies and healthcare centers in Germany.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Mediwhale Inc.
South Korea · 4 relevant products
ZD Medical Inc.
China · 3 relevant products
Anhui Huibang Biological Engineering Co., Ltd.
China · 4 relevant products
8 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 20 closest product alternatives
Mediwhale Inc. · South Korea
Automated deep learning system that identifies various retinal diseases from fundus photographs. Provides comprehensive retinal disease screening capability integrated into routine eye examination workflows.
ZD Medical Inc. · China
A diagnostic instrument for dry eye disease detection and analysis. This device provides comprehensive assessment of dry eye conditions in clinical settings.
Anhui Huibang Biological Engineering Co., Ltd. · China
An in vitro detection system for early diagnosis indicators of diabetic nephropathy in human urine. It features multi-channel composite detection with selected indicator combinations including urinary microalbumin, urinary haptoglobin, and urinary creatinine as an internal standard. The system uses dry biochemistry and immunology methods, allows random urine self-testing without invasive procedures, and supports home-based testing with mobile device image upload for server analysis and professional feedback.
17 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products